What adverse effects can occur in newborns exposed to paliperidone during the third trimester of pregnancy?

Newborns exposed to paliperidone during the third trimester are at risk of extrapyramidal and/or withdrawal symptoms of varying severity and duration after delivery, including agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress or feeding disorder, and should be carefully monitored.